1.
|
Phase: Phase IV
Type: Treatment
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT_2010-021786-78, NCT01255644
|
|
2.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: 1577.00, FHCRC-1577.00, MSKCC-01127, NCI-H01-0072, NCT00016068
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-05-C-0203, NCI-P6330, NCT00217503
|
|
4.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCSD-050126, ROCHE-VAL-108, NCT00387530
|
|
5.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000393194, MSKCC-04055, NCT00096538
|
|
6.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MV20145, Eudra CT: 2006-002022-29, NCT00400322
|
|
7.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09038, NCI-2010-01932, NCT01199562
|
Mobile | Español
